| Search by tag or site | Login to my blog ? Start my own blog |
 |
BioHealth InvestorBioHealth Investor (BHI) is a blog and journal focused on providing updated commentary and financial news from the biotech and medical technology industry. BHI's content is featured on Yahoo!Finance, Google Finance, TheStreet.com, SeekingAlpha.com and many other blogs and websites. BHI is also a proud member of The Business of Biotech Network, and the Investors Blog Network. |
Audioconference: "strategies To Defend Against Generic Drug Patent Challenges"
Posted on 03/08/2007 17:10:00 | Link | Post Comment
by Aaron F. Barkoff
Orange Book Blog
Paul Berghoff, Josh Rich, and I will be speaking in an FDANews audioconference next week entitled "Strategies to Defend Against Generic Drug Patent Challenges." Paul is a first-chair patent litigator who has tried numerous Hatch-Waxman cases, while Josh has spent over a decade litigating such cases. The audioconference will take place from 1:30 to 3:00 p.m. (eastern), next Wednesday, March 14--one week from today.
The audioconference will include a 60-minute presentation (with materials provided), followed by a question-and-answer session. In our presentation, we plan to cover the following topics:
We hope the audioconference will be useful to both innovator and generic drug companies involved in Hatch-Waxman litigation. For more information or to register, please visit the audioconference web-page.
Source: OrangeBookBlog.com
____________________
Orange Book Blog
Paul Berghoff, Josh Rich, and I will be speaking in an FDANews audioconference next week entitled "Strategies to Defend Against Generic Drug Patent Challenges." Paul is a first-chair patent litigator who has tried numerous Hatch-Waxman cases, while Josh has spent over a decade litigating such cases. The audioconference will take place from 1:30 to 3:00 p.m. (eastern), next Wednesday, March 14--one week from today.
The audioconference will include a 60-minute presentation (with materials provided), followed by a question-and-answer session. In our presentation, we plan to cover the following topics:
fundamentals of Hatch-Waxman cases
strategies for dealing with invalidity, unenforceability, and non-infringement challenges
strategies for defending the various kinds of pharmaceutical patents (e.g., compound, method of use, formulation, etc.)
the impact of recent Supreme Court cases, including MedImmune and eBay; and
the potential impact of proposed legislation
We hope the audioconference will be useful to both innovator and generic drug companies involved in Hatch-Waxman litigation. For more information or to register, please visit the audioconference web-page.
Source: OrangeBookBlog.com
____________________
- Mri To Lead Growth In Medical-imaging Market
- Malaria And Hiv - Eradication And Treatment
- Dragon’s New Production Process To Cut Costs
- Mrsa Update: Cepheid, Basilea And Nektar
- If Only Us Health Care Could Be More Like The Patriots (or Even The Red Sox) And Less Like The Yankees
- Credit Bloggers
- The Average Joe Investor
- Wishing Wealth
- Financial Skeptic
- Edmonton Real Estate
- Don't Mess With Taxes
Examples
Morpheus Trading - Mon Jul 21, 2008 08:33AM
NOTE: Please click on the charts below to enlarge them if [read more]
NOTE: Please click on the charts below to enlarge them if [read more]
Morpheus Trading - Mon Jul 21, 2008 08:31AM
NOTE: Please click on the charts below to enlarge them i [read more]
NOTE: Please click on the charts below to enlarge them i [read more]
Millionaire Now! by Larry Nusbaum - Tue Jul 22, 2008 09:23AM
Hedge funds have made billions this year shorting the banks, [read more]
Hedge funds have made billions this year shorting the banks, [read more]
1 Comments:
doqr lyhsqr ntbqlcdwh xdnqoc xemhjp sekg ngxthpose
<< My Home | TheMoneyBlogs Home